Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03637543 |
|
Recruitment Status :
Recruiting
First Posted : August 20, 2018
Last Update Posted : September 22, 2020
|
Sponsor:
Beth Israel Deaconess Medical Center
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
David J. Einstein, MD, Beth Israel Deaconess Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | March 31, 2022 |
| Estimated Study Completion Date : | March 31, 2025 |